Results 221 to 230 of about 203,879 (305)

Ex Vivo Effect of Apixaban on Hemostatic Biomarkers in Children With Heart Disease: A SAXOPHONE Trial Substudy. [PDF]

J Am Heart Assoc
Aborkhees GA, Barr AJ, Dietrich K, Male C, Wang Z, Yao C, Payne RM, Glatz AC, Monagle P, Burns KM, Reedy AM, Dyme JL, Schafer PH, Ajavon-Hartmann A, Mitchell LG.   +14 more
europepmc   +1 more source

Bivalirudin for Recurrent Pediatric Venous Thromboembolism: A Case Report of Heparin Resistance and Thrombectomy. [PDF]

J Med Cases
Shelley S, Matthews Richards L.
europepmc   +1 more source

PD0325901 alleviates thrombin-inhibited osteogenic differentiation through an IL-1β-activated feedback loop between MEK-Erk1/2 and NF-κB signal pathways: insights from bioinformatics and experimental verification. [PDF]

Front Immunol
Ge YS, Huang CM, Shen J, Meng TT, Zhao MJ, Yin JL, Huang XH, Chen LL, Luo JH, Zhai YQ, Du JW, Wang YL, Wang XZ, Sun PP, Ding DF.   +14 more
europepmc   +1 more source

Non-factor Therapies in Hemophilia: Mechanisms, Clinical Evidence, Patient Management, and Future Perspectives. [PDF]

Adv Ther
Nakajima Y, Nogami K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Thrombin generation and fibrin clot structure

Blood Reviews, 2007
Alisa S Wolberg
exaly   +2 more sources

Aptamer/thrombin/aptamer-AuNPs sandwich enhanced surface plasmon resonance sensor for the detection of subnanomolar thrombin

Biosensors and Bioelectronics, 2013
Feng Feng, Xiaoxiao He, Yunfeng Bai
exaly   +2 more sources

Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors

Blood Coagulation & Fibrinolysis, 2007
For intravenous anticoagulation, heparin has been the mainstay drug, but its use may be contraindicated in heparin-induced thrombocytopenia and thrombosis. Heparin alternatives including direct thrombin inhibitors are available, but clotting assays (e.g.
Taro, Taketomi, Fania, Szlam, Jakob, Vinten-Johansen, Jerrold H, Levy, Kenichi A, Tanaka   +4 more
openaire   +2 more sources

Thrombin and acetylated thrombin in the activation of fibrinolysis

Canadian Journal of Physiology and Pharmacology, 1968
Thrombin that has been acetylated on its free amino group loses its fibrinogen-clotting properties, but when injected intravenously produces a fibrinolytic syndrome. The lytic results compare very closely to those obtained with thrombin administration, but acetylated thrombin does not produce fibrin deposition.
R H, Landaburu, E, Giavedoni, R, Santillán   +2 more
openaire   +2 more sources